TheFiscalFinder
● PSC category

Health R&D Services; Health Care Services; Experimental Development

PSC AN13
$1.4B
federal awards, FY2023
PSC AN13
code

Obligations by year

≈ computed
$1.4B
FY23
$564M
FY24
$120.1M
FY25
▼ 91%
since FY23

Top recipients

No recipients recorded.

Top funding agencies

No agencies recorded.

Largest awards in this category

Contract DAMD1798C8024
awarded 1997$803.3M
Treatment for Use in a Mass Casualty Event Where Thrombocytopenia or Platelet…
awarded 2022$773.9M
Contract HHSO100201700016C
awarded 2017$693.1M
Procurement and Late-Stage Development of Smallpox Antiviral Drug(s)
awarded 2018$624.4M
Emergent Ciadm Manufacturing Capacity Reservation and Expansion
awarded 2020$470.9M
Regeneron Other Transaction Authority (Ota) Award
awarded 2017$279.6M
Advance Development of New Antiviral Agent for Influenza
awarded 2007$205M
Contract HHSO10033001T
awarded 2013$196.4M

Total value over each award’s life, largest first.

Related product & service codes

Health R&D Services; Health Care - Other; Applied Research$2.4B
Health R&D Services; Health Care Services; Basic Research$1.9B
Health R&D Services; Health Care Services; Applied Research$1.8B
Health R&D Services; Health Care - Other; Basic Research$464M
Health R&D Svcs; Consumer & Occupational Health & Safety; R&D Facilities & Maj Equip$144.8M
R&D- Medical: Biomedical (Commercialized)$52M
R&D- Medical: Specialized Medical Services (Advanced Development)$45.2M
R&D- Medical: Health Services (Management/Support)$43.4M